BEIJING, Oct. 27, 2020 /PRNewswire/ — Collective testing served as a critical approach in China for emergency response in face of the coronavirus outbreak.
In mid-October, a cluster of COVID-19 infections was found in Qingdao.
The local government immediately organized a collective nucleic acid testing for 10 million people within five days.
Back in June, as the cluster of COVID-19 infections linked to Beijing’s Xinfadi Agricultural Produce Wholesale Market emerged, Beijing municipal government started to call on citizens to receive nucleic acid testing.
Up to July 11, 11.88 million people have done the test, accounting for half of the permanent residents in Beijing. The number of testing institutions in Beijing rose to 194 by the end of June, with a daily testing volume of 458,000. It helped a lot to filtrate the infected cases.
Out of the required demand for a trip outside Beijing, British journalist and host Josh from China Matters received nucleic acid testing right as the cluster of new infections was found in Beijing and the whole process was filmed.
This video shows the process of making test appointment online, collecting throat swabs, and receiving report through phones. The first-hand observation and feelings by the host Josh on the spot make the video vivid and unique.
Video – https://mma.prnewswire.com/media/1321162/China_Matters_Testing_COVID_19_Beijing.mp4
Logo – https://healthtechnologynet.com/wp-content/uploads/2020/10/China_Matters_Logo.jpg
Contact: Li Siwei
Tel.: +8610-68996566
E-mail: lisiwei5125@gmail.com
Facebook: https://business.facebook.com/watch/?v=1555325854650363
YouTube: https://youtu.be/rPRj_wzDreo
SOURCE China Matters
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…